Literature DB >> 1794604

Prolactin receptor gene expression in lymphoid cells.

K D O'Neal1, L A Schwarz, L Y Yu-Lee.   

Abstract

To understand the role of pituitary prolactin (PRL) and its receptor (PRL-R) in the growth and differentiation of lymphoid cells, PRL-R gene expression was analyzed in various lymphoid tissues and in a rat T lymphoma cell line, Nb2, which requires PRL for growth. The technique of reverse transcription coupled to polymerase chain reaction (RT-PCR) was used to detect the low abundance PRL-R transcripts. Within 30 min to 1 h, PRL stimulates a rapid but transient increase in PRL-R mRNA levels in Nb2 T cells. By 4 h, PRL-R mRNA returned to near basal levels and then gradually declined to a new steady-state level by 12 h. Significant increases in receptor RNA levels were observed in the presence of protein synthesis inhibitors, which suggests that PRL-R mRNA levels are under negative regulation. PRL-R gene expression was also demonstrated in normal mouse thymocytes, splenocytes, and in several lymphoid cell lines. The expression of the PRL-R gene in stimulated lymphoid cells provides additional evidence for the role of PRL as an immunomodulatory molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1794604     DOI: 10.1016/0303-7207(91)90023-l

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  Modulation of growth factor receptor function by isoform heterodimerization.

Authors:  W P Chang; C V Clevenger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 2.  Primary pituitary lymphoma: an update of the literature.

Authors:  A Tarabay; G Cossu; M Berhouma; M Levivier; R T Daniel; M Messerer
Journal:  J Neurooncol       Date:  2016-08-31       Impact factor: 4.130

3.  Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene.

Authors:  N D Horseman; W Zhao; E Montecino-Rodriguez; M Tanaka; K Nakashima; S J Engle; F Smith; E Markoff; K Dorshkind
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

4.  Up-regulation of the human prolactin receptor in the endometrium.

Authors:  H Jikihara; C A Kessler; M I Cedars; A K Brar
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

5.  Pituitary lymphoma developing within pituitary adenoma.

Authors:  Ken Morita; Fumihiko Nakamura; Yasuhiko Kamikubo; Naoaki Mizuno; Masashi Miyauchi; Go Yamamoto; Yasuhito Nannya; Motoshi Ichikawa; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2012-04-21       Impact factor: 2.490

6.  Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.

Authors:  T Bauernhofer; I Kuss; U Friebe-Hoffmann; A S Baum; G Dworacki; B K Vonderhaar; T L Whiteside
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

7.  Immunoendocrine mechanisms in mammary tumor progression: direct prolactin modulation of peripheral and preneoplastic hyperplastic-alveolar-nodule- infiltrating lymphocytes.

Authors:  S C Tsai; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

8.  Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques.

Authors:  C Bole-Feysot; E Perret; P Roustan; B Bouchard; P A Kelly
Journal:  Genome Biol       Date:  2000-10-16       Impact factor: 13.583

9.  Concomitant Primary CNS Lymphoma and FSH-Pituitary Adenoma Arising Within the Sella. Entirely Coincidental?

Authors:  Vin Shen Ban; Bedansh Roy Chaudhary; Kieren Allinson; Thomas Santarius; Ramez Wadie Kirollos
Journal:  Neurosurgery       Date:  2017-01-01       Impact factor: 4.654

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.